Article Text

Review: antibiotic prophylaxis reduces mortality in patients with neutropenia

Statistics from

 Q Does antibiotic prophylaxis, particularly fluoroquinolone prophylaxis, reduce mortality in patients with neutropenia?


Embedded ImageData sources:

Medline (1966–2004), EMBASE/Excerpta Medica (1980–2004), Cochrane Cancer Network register of trials (December 2004), Cochrane Library (Issue 4, 2004), and references of included studies and reviews.

Embedded ImageStudy selection and assessment:

published and unpublished randomised controlled trials (RCTs) in any language that compared antibiotic therapy with placebo, no intervention, or other antibiotics for prophylaxis of bacterial infection in patients with neutropenia. Individual study quality was assessed based on allocation concealment, generation of allocation sequence, blinding, and intention to treat analysis.

Embedded ImageOutcomes:

primary outcome was all cause mortality; secondary outcomes included infection related mortality, fungal infection, adverse events, and risk of harbouring drug resistant bacilli.


95 RCTs (n = 9283, mostly adults) met the selection criteria. 64 trials included …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.